ID   M4Be IC8
AC   CVCL_C3PR
SY   IC8; Clone 1
DR   Wikidata; Q116049750
RX   DOI=10.1159/000417158;
RX   DOI=10.1159/000417159;
RX   PubMed=1503405;
RX   PubMed=1937961;
RX   PubMed=7874696;
RX   PubMed=8012932;
RX   PubMed=8175891;
RX   PubMed=9043018;
CC   Characteristics: Low metastatic potential.
CC   Doubling time: 30 +- 0.5 hours (PubMed=8175891).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
RX   DOI=10.1159/000417158;
RA   Bertrand S., Bailly M., Nguyen M.-J., Dore J.-F.;
RT   "Cytogenetic characterization of human melanoma metastatic variants:
RT   role of chromosome 7?";
RL   (In book chapter) Immune-deficient animals in experimental medicine; Wu B.-Q., Zheng J. (eds.); pp.135-139; Karger; Basel; Switzerland (1989).
//
RX   DOI=10.1159/000417159;
RA   Bailly M., Bertrand S., Dore J.-F.;
RT   "Experimental model of human tumor spontaneous metastasis in immunosupressed
RT   newborn rat.";
RL   (In book chapter) Immune-deficient animals in experimental medicine; Wu B.-Q., Zheng J. (eds.); pp.140-146; Karger; Basel; Switzerland (1989).
//
RX   PubMed=1503405;
RA   Bailly M., Dore J.-F.;
RT   "Clonal drift and role of chromosome dosage in human melanoma
RT   metastatic cell lines: a statistical analysis.";
RL   Anticancer Res. 12:1163-1172(1992).
//
RX   PubMed=1937961; DOI=10.1002/ijc.2910490520;
RA   Bailly M., Dore J.-F.;
RT   "Human tumor spontaneous metastasis in immunosuppressed newborn rats.
RT   II. Multiple selections of human melanoma metastatic clones and
RT   variants.";
RL   Int. J. Cancer 49:750-757(1991).
//
RX   PubMed=7874696; DOI=10.1016/0304-3835(94)03624-r;
RA   Thomas C.P., Buronfosse A., Portoukalian J., Fertil B.;
RT   "Correlation between the radiosensitivity in vitro of clones and
RT   variants derived from a human melanoma cell line and their
RT   spontaneous metastatic potential in vivo.";
RL   Cancer Lett. 88:221-225(1995).
//
RX   PubMed=8012932; DOI=10.1016/0304-3835(94)90197-x;
RA   Mey A., Berthier-Vergnes O., Apoil P.A., Dore J.-F., Revillard J.-P.;
RT   "Expression of the galactose binding protein Mac-2 by human melanoma
RT   cell-lines.";
RL   Cancer Lett. 81:155-163(1994).
//
RX   PubMed=8175891; DOI=10.1002/jcb.240540205;
RA   Zebda N., Bailly M., Brown S., Dore J.-F., Berthier-Vergnes O.;
RT   "Expression of PNA-binding sites on specific glycoproteins by human
RT   melanoma cells is associated with a high metastatic potential.";
RL   J. Cell. Biochem. 54:161-173(1994).
//
RX   PubMed=9043018; DOI=10.1038/bjc.1997.115; PMCID=PMC2063334;
RA   Thomas C.P., Buronfosse A., Portoukalian J., Fertil B.;
RT   "The gangliosides as a possible molecular coupling factor between the
RT   proportion of radiosensitive cells in vitro and the metastatic
RT   potential in vivo within a human melanoma cell line.";
RL   Br. J. Cancer 75:639-649(1997).
//